Moderna Warns that New Variants of Covid-19 are Coming
By Jesse Smith
The fear-mongering I warned about regarding new variants of COVID-19 in my “Get Ready for COVID-21” article from January is picking up steam. Recently, scientists and executives from Moderna began sounding the alarm that the current crop of “vaccines” wouldn’t be enough to stem the tide of newly emerging COVID variants that are more even transmissible.
An article from Deadline highlighted comments from Moderna’s chief scientific officer Melissa Moore, who stated:
As the virus spreads, it is rapidly mutating. Some of these new viral strains appear to be even more transmissible than the original strain… We already know that some of these new strains are less susceptible to neutralization by our current vaccine.
Also quoted in the article was Moderna scientist and associate director of the infectious disease team, Guillaume Stewart-Jones, who stated:
The shortest time from the detection of a variant of concern to preclinical immunogenicity readout against a panel of pseudoviruses is approximately 2 to 3 months…And new viral variants are coming — emerging constantly in real time.
The article goes on to suggest, “…while it’s generally acknowledged that most variants will not morph into something more fatal than the current virus, there are no guarantees.”
Regarding the need for COVID booster shoots, a recent Motley Fool article, added:
…The bottom line is that booster shots and new vaccines targeting the variants will likely be needed.
Dr. Anthony Fauci, chief medical advisor to President Biden and longtime head of the National Institute of Allergy and Infectious Diseases, thinks that we won’t know for sure if booster doses are needed until the fall. Moderna’s research appears to indicate that it’s not a question of if but when booster shots will be required.
It makes perfect sense that Moderna, who recently filed for full FDA approval of its COVID “vaccine” (following Pfizer’s request last month) would cite the need for booster shots as they stand gain even greater financial benefit. Motley Fool goes on to document the potential financial windfall that awaits the major “vaccine” makers:
Arguably the most likely to succeed in the variant-focused COVID-19 vaccine market are the drugmakers that have already been the most successful: Moderna and Pfizer (along with its partner BioNTech)Why? Perhaps most important, their messenger RNA technology allows these companies to rapidly develop variant-specific vaccines. Moderna and Pfizer are already in testing with their respective variant-specific candidates.
But has the rise of the coronavirus variants already been priced into these stocks? You might think that’s the case for Moderna and BioNTech. The biotech stocks have soared nearly 80% and more than 150% year to date, respectively. Pfizer’s shares, though, are up only 5% this year.
However, all three of these stocks trade at low forward-earnings multiples. If the coronavirus continues to mutate and force the need for new variant-specific vaccines to keep the pandemic at bay, Moderna, Pfizer, and BioNTech could have plenty of room to run.
An Atlantic article from March also underscored the need for new vaccines while warning about COVID-21, stating:
It’s worth considering a new way of thinking about the period of the pandemic now ahead of us—one that leads us neither to complacency nor to paralyzing despair. In many ways COVID-19 is already over. What lies ahead is COVID-21.
COVID-21 is the product of all these changes in aggregate. It’s the disease as it will be experienced in the months and years to come: with new variants of the virus, new public policies and health behaviors, various degrees of immune memory, and—most important—a cavalcade of new vaccines.
All of this will certainly help sell more vaccines in the form of booster shots as Sharon Peacock, UK Covid-19 Genomics (COG-UK) chief warned were inevitable earlier this year, disclosing:
We have to appreciate that we were always going to have to have booster doses; immunity to coronavirus doesn’t last forever… We already are tweaking the vaccines to deal with what the virus is doing in terms of evolution – so there are variants arising that have a combination of increased transmissibility and an ability to partially evade our immune response.
In a 2020 report by Public Citizen, it was revealed that the National Institutes of Health (NIH) maintains a joint stake with Moderna in the development of an mRNA coronavirus vaccine and could collect half the royalties. The report revealed that:
The U.S. government may jointly own a potential COVID-19 vaccine. At least two patent applications that appear essential to the vaccine name federal scientists as inventors, giving the U.S. government ownership if the patents are granted. Collaboration agreements also support the government’s ownership stake in mRNA-1273.
Regarding the money to be made from new mRNA vaccines and boosters, Jon Rappoport recently wrote:
The fake pandemic was their golden opportunity to win approval for the first RNA pharma product in history, and once that victory was achieved—
They would beat the drum for new RNA vaccines, WHICH ARE CHEAPER, EASIER, AND FASTER TO MANUFACTURE, AND FAR MORE PROFITABLE.
So, while the government and Big Pharma are busy enriching themselves from patented mRNA inventions those who have been duped into taking this poison are paying the price as the depopulation agenda rears its ugly head.
Instead of booster shots, the COVID “vaccine” campaign should be stopped immediately! Governments hypocritically locked down their populations for months claiming if even one person died from coronavirus it was too many. Now that there are hundreds of thousands (see VAERS, EudraVigilance, and VigiAccess) of reports of death, hospitalizations, allergic reactions, miscarriages, heart attacks, Bell’s palsy, myocarditis, and more, governments have been complicit in letting multitudes suffer fates equal to or even worse than what COVID-19 has wrought.
All the emphasis on COVID variants from the vaccine makers and their stooges flies in the face of recent revelations offered by French Nobel Prize winning virologist Luc Montagnier. A New American article documents Montagnier’s argument that the COVID “vaccines” are actually causing new variants or mutations.
The vaccines don’t stop the virus, argues the prominent virologist, they do the opposite — they “feed the virus,” and facilitate its development into stronger and more transmittable variants. These new virus variants will be more resistant to vaccination and may cause more health implications than their “original” versions.
During the interview, professor Montagnier referred to the vaccine program for the coronavirus as an “unacceptable mistake.” Mass vaccinations are a “scientific error as well as a medical error,” he said. “The history books will show that, because it is the vaccination that is creating the variants.” Montagnier explained that “there are antibodies, created by the vaccine,” forcing the virus to “find another solution” or die. This is where the variants are created. It is the variants that “are a production and result from the vaccination.”
The fact-checking frenzy went into overdrive to debunk Montagnier’s theories. Montagnier was a media darling after winning the Nobel Prize in 2008 for discovering HIV. Now that he is contradicting the Big Pharma narrative on the COVID “vaccines”, he is being vilified. Regardless of whether or not his theories are true, there should at least be an open scientific debate instead of a rush to quell theories that contradict the variant scare narrative.
Fear is a handy tool used to subdue the population so be watchful as this narrative gains steam. If the FDA grants Moderna and Pfizer/BioNTech full approval of these experimental mRNA technologies, it could open the door to enact mandatory vaccination and booster shot policies on a wide scale. The attacks against those who refuse to roll up their sleeves may only get more vicious in the weeks and months to come as I warned in The Vaccine Divide and Emerging Segregation Society.
Source: Truth Unmuted